PSA | ||
|---|---|---|
OUTLOOK RATING 1..100 | 56 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | |
PROFIT vs RISK RATING 1..100 | 59 | |
SMR RATING 1..100 | 31 | |
PRICE GROWTH RATING 1..100 | 62 | |
P/E GROWTH RATING 1..100 | 65 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| DFAR | PSA | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 77% |
| Stochastic ODDS (%) | 2 days ago 83% | 2 days ago 63% |
| Momentum ODDS (%) | 2 days ago 78% | 2 days ago 48% |
| MACD ODDS (%) | 2 days ago 77% | 2 days ago 45% |
| TrendWeek ODDS (%) | 2 days ago 83% | 2 days ago 50% |
| TrendMonth ODDS (%) | 2 days ago 82% | 2 days ago 51% |
| Advances ODDS (%) | 9 days ago 83% | 25 days ago 58% |
| Declines ODDS (%) | N/A | 10 days ago 55% |
| BollingerBands ODDS (%) | 3 days ago 79% | 2 days ago 72% |
| Aroon ODDS (%) | 7 days ago 74% | 2 days ago 48% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AIRR | 98.04 | 0.26 | +0.27% |
| First Trust RBA Amer Indl RenaisTM ETF | |||
| MAXJ | 28.23 | 0.01 | +0.03% |
| iShares Large Cap Max Buffer Jun ETF | |||
| GDOC | 35.90 | N/A | N/A |
| Goldman Sachs Future Health Care Eq ETF | |||
| XEMD | 44.48 | -0.01 | -0.02% |
| BondBloxx JP Morgan USD EM 1-10 Yr BdETF | |||
| BAMG | 40.04 | -0.11 | -0.27% |
| Brookstone Growth Stock ETF | |||
A.I.dvisor indicates that over the last year, DFAR has been closely correlated with EQR. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if DFAR jumps, then EQR could also see price increases.
| Ticker / NAME | Correlation To DFAR | 1D Price Change % | ||
|---|---|---|---|---|
| DFAR | 100% | -0.84% | ||
| EQR - DFAR | 85% Closely correlated | -1.44% | ||
| UDR - DFAR | 84% Closely correlated | -0.60% | ||
| STAG - DFAR | 82% Closely correlated | -0.86% | ||
| CPT - DFAR | 82% Closely correlated | -0.95% | ||
| PSA - DFAR | 82% Closely correlated | -0.98% | ||
More | ||||
A.I.dvisor indicates that over the last year, PSA has been closely correlated with EXR. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if PSA jumps, then EXR could also see price increases.